Abiopharma

IFF 發佈《2024 Do More Good Report》彰顯可持續發展與創新成果

New Form 4 - PRECISION BIOSCIENCES INC Filed: 2025-06-27 AccNo: 0001628280-25-033199 Size: 5 KB

New Form 4 - SeaStar Medical Holding Corp Filed: 2025-06-27 AccNo: 0001213900-25-058569 Size: 5 KB

New Form EFFECT - 180 Life Sciences Corp. Filed: 2025-06-26 AccNo: 9999999995-25-002043 Size: 1 KB

New Form EFFECT - Connect Biopharma Holdings Ltd Filed: 2025-06-26 AccNo: 9999999995-25-002040 Size: 1 KB

New Form EFFECT - Ontrak, Inc. Filed: 2025-06-26 AccNo: 9999999995-25-002041 Size: 2 KB

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

FDA approve PURIFIED WATER

FDA approve METHADONE HYDROCHLORIDE

FDA approve FAMOTIDINE

FDA approve METOPROLOL SUCCINATE

FDA approve DOXORUBICIN HYDROCHLORIDE

FDA approve NICARDIPINE HYDROCHLORIDE

General Announcement: COMPLETION OF THE PROPOSED DISPOSAL OF THE REMAINING 12% EQUITY INTEREST IN TSKF

Tilray Medical publie une recherche pionnière sur la pharmacocinétique des formulations de THC et de CBD